• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Medpace Buys Medical Device CRO Symbios

Medpace Buys Medical Device CRO Symbios

April 7, 2010
CenterWatch Staff

Cincinnati-based contract research organization (CRO) Medpace acquired medical device CRO Symbios for an undisclosed amount. Symbios was advised by Fairmount Partners in this transaction.

Symbios supports medical device research with experience in pre-market, post-approval and post-market clinical trials. The company will continue to operate out of its Minneapolis, Minn., headquarters. Symbios’ founder and CEO Ryan Wilson and his management team will continue to lead Medpace’s medical device business, now named Symbios Clinical, as a member of the Medpace group of companies.

“The ability of Medpace to tap into this innovative company for benefit of our existing and new Sponsors will be valuable as yet another service area for Medpace, and allow Symbios to benefit from our established global infrastructure,” said Medpace president and CEO August Troendle in a statement.

Medpace offers services in phase I to IV clinical trial management, bio-imaging, central laboratory and clinical pharmacology. The CRO has European headquarters in The Netherlands, Asian headquarters in Singapore and regional offices throughout Europe, Asia, Australia, South Africa and the Americas.

Earlier this year, the company acquired Germany-based CRO Medical Consulting Dr. Schlichtiger. At the time, Medpace had 1,000 employees worldwide but announced plans to almost double its headcount by 2014.

 

Upcoming Events

  • 15Apr

    Five Telltale Signs You’re Ready for an Electronic TMF System

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

  • 06May

    The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Clinical-Trial-Brainstorming

    FDA, Industry Tackle Problem of Including Older Adults in Trials

  • ClinicalTrialNetwork-360x240.png

    National Community-Based Research Network Would Improve Reach of Trials

  • Bottleneck-360x240.png

    Sites Face Trials Bottleneck After Pandemic, But Also Opportunities

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Genetic Research and IBC Oversight Requirements

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing